Topical timolol for infantile hemangioma of the eyelid

International Journal of Dermatology

Volumn 52, Issue 5, 2013, Pages 603-604

  Calvo, María ^a   Garcia Millán, Cristina ^a   Villegas, Cristina ^a   Fueyo Casado, Alejandro ^a   Burón, Isabel ^a  

^a Sanitas La Moraleja Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

TIMOLOL;

ARTICLE; CAPILLARY HEMANGIOMA; CASE REPORT; DRUG MONITORING; DRUG TOLERANCE; EYELID DISEASE; HUMAN; INFANT; MALE; PHOTOGRAPHY; PTOSIS; TREATMENT RESPONSE; TUMOR VOLUME;

ADMINISTRATION, CUTANEOUS; ADRENERGIC BETA-ANTAGONISTS; EYELID NEOPLASMS; HEMANGIOMA, CAPILLARY; HUMANS; INFANT, NEWBORN; MALE; NEOPLASTIC SYNDROMES, HEREDITARY; OPHTHALMIC SOLUTIONS; TIMOLOL;

EID: 84876446013     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.05290.x     Document Type: Article

References (7)

1. Drolet BA, Esterly NB, Frieden IL. Hemangiomas in children. N Engl J Med 1999; 341: 173-181.
2. Schwartz SR, Blei F, Ceisler E, et al. Risk factors for amblyopia in children with capillary hemangiomas of the eyelids and orbit. JAAPOS 2006; 10: 262-268.
3. Leaute-Labreze C, Dumas de la Roque E, Hubiche T, et al. Propanolol for severe hemangiomas of infancy. N Engl J Med 2008; 358: 2649-2651.
4. Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol 2010; 128: 255-256.
5. Ni N, Langer P, Wagner R, Guo S. Topical timolol for periocular hemangima: report of further study. Arch Ophthalmol 2011; 129: 377-379.
6. Pope E, Chakkittakandiyil A. Topical timolol gel for infantile hemangiomas: a pilot study. Arch Dermatol 2010; 146: 564-565.
7. D'Angelo G, Lee H, Weiner RI. The cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblastic growth factor in capillary endothelial cells by blocking Raf activation. J Cell Biochem 1997; 67: 353-366.